Showing 1 - 2 results of 2 for search 'David R. Camidge', query time: 0.02s Refine Results
  1. 1
    Association of anticoagulant use with clinical outcomes from crizotinib in ALK‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001

    Association of anticoagulant use with clinical outcomes from crizotinib in ALK‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001... by Terry L. Ng, David C. C. Tsui, Sherry Wang, Tiziana Usari, Tejas Patil, Keith Wilner, David R. Camidge

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC

    Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC by Neeraj Gupta, Karen L. Reckamp, David R. Camidge, Huub J. Kleijn, Aziz Ouerdani, Francesco Bellanti, John Maringwa, Michael J. Hanley, Shining Wang, Pingkuan Zhang, Karthik Venkatakrishnan

    Published 2022-05-01
    Get full text
    Article

Search Tools: